Cockwell P, Fisher L-A. The global burden of chronic kidney disease. Lancet 2020; 395:662–664. doi: 10.1016/S0140-6736(19)32977-0

• PubMed
Cockwell P, Fisher L-A. The global burden of chronic kidney disease. Lancet 2020; 395:662–664. doi: 10.1016/S0140-6736(19)32977-0)| false
• Search Google Scholar
• Export Citation

Hingorani S, et al. Urinary cytokines after HCT: Evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant 2014; 49:403–409. doi: 10.1038/bmt.2013.197

• PubMed
Hingorani S, Urinary cytokines after HCT: Evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease. Bone Marrow Transplant 2014; 49:403–409. doi: 10.1038/bmt.2013.197)| false
• Search Google Scholar
• Export Citation

Zhou W, et al. Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population. Clin Transplant 2017; 31:e12920. doi: 10.1111/ctr.12920

• PubMed
Zhou W, Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population. Clin Transplant 2017; 31:e12920. doi: 10.1111/ctr.12920)| false
• Search Google Scholar
• Export Citation

Weiss AS, et al. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6:89–94. doi: 10.1111/j.1600-6143.2005.01131.x

• PubMed
Weiss AS, Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6:89–94. doi: 10.1111/j.1600-6143.2005.01131.x)| false
• Search Google Scholar
• Export Citation

Saddadi F, et al. Chronic kidney disease after hematopoietic cell transplantation: Frequency, risk factors, and outcomes. Transplant Proc 2009; 41:2895–2897. doi: 10.1016/j.transproceed.2009.07.093

• PubMed
Saddadi F, Chronic kidney disease after hematopoietic cell transplantation: Frequency, risk factors, and outcomes. Transplant Proc 2009; 41:2895–2897. doi: 10.1016/j.transproceed.2009.07.093)| false
• Search Google Scholar
• Export Citation

Pelletier K, et al. Chronic kidney disease, survival and graft-versus-host-disease/relapse-free survival in recipients of allogeneic hematopoetic stem cell transplant. Clin Kidney J [published online April 7, 2022]. https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfac091/6564752?login=false

• PubMed
Pelletier K, Chronic kidney disease, survival and graft-versus-host-disease/relapse-free survival in recipients of allogeneic hematopoetic stem cell transplant. Clin Kidney J [published online April 7, 2022]. https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfac091/6564752?login=false)| false
• Search Google Scholar
• Export Citation

Ellis MJ, et al. Chronic kidney disease after hematopoietic cell transplantation: A systematic review. Am J Transplant 2008; 8:2378–2390. doi: 10.1111/j.1600-6143.2008.02408.x

• PubMed
Ellis MJ, Chronic kidney disease after hematopoietic cell transplantation: A systematic review. Am J Transplant 2008; 8:2378–2390. doi: 10.1111/j.1600-6143.2008.02408.x)| false
• Search Google Scholar
• Export Citation

Ando M, et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: Prevalence and risk factors. Nephrol Dial Transplant 2010; 25:278–282. doi: 10.1093/ndt/gfp485

• PubMed
Ando M, Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: Prevalence and risk factors. Nephrol Dial Transplant 2010; 25:278–282. doi: 10.1093/ndt/gfp485)| false
• Search Google Scholar
• Export Citation

Abramson MH, et al. Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation. Clin J Am Soc Nephrol 2021; 16:1318–1327. doi: 10.2215/CJN.19801220

• PubMed
Abramson MH, Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation. Clin J Am Soc Nephrol 2021; 16:1318–1327. doi: 10.2215/CJN.19801220)| false
• Search Google Scholar
• Export Citation

Jo T, et al. Chronic kidney disease in long-term survivors after allogeneic hematopoietic stem cell transplantation: Retrospective analysis at a single institute. Biol Blood Marrow Transplant 2017; 23:2159–2165. doi: 10.1016/j.bbmt.2017.08.016

• PubMed
Jo T, Chronic kidney disease in long-term survivors after allogeneic hematopoietic stem cell transplantation: Retrospective analysis at a single institute. Biol Blood Marrow Transplant 2017; 23:2159–2165. doi: 10.1016/j.bbmt.2017.08.016)| false
• Search Google Scholar
• Export Citation

Touzot M, et al. Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: A single-centre study. Nephrol Dial Transplant 2010; 25:624–627. doi: 10.1093/ndt/gfp529

• PubMed
Touzot M, Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: A single-centre study. Nephrol Dial Transplant 2010; 25:624–627. doi: 10.1093/ndt/gfp529)| false
• Search Google Scholar
• Export Citation

Hingorani S, et al. Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: A prospective cohort study. Clin J Am Soc Nephrol 2018; 13:866–873. doi: 10.2215/CJN.10630917

• PubMed
Hingorani S, Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: A prospective cohort study. Clin J Am Soc Nephrol 2018; 13:866–873. doi: 10.2215/CJN.10630917)| false
• Search Google Scholar
• Export Citation

Sedhom R, et al. Mini-review of kidney disease following hematopoietic stem cell transplant. Clin Nephrol 2018; 89:389–402. doi: 10.5414/CN109276

• PubMed
Sedhom R, Mini-review of kidney disease following hematopoietic stem cell transplant. Clin Nephrol 2018; 89:389–402. doi: 10.5414/CN109276)| false
• Search Google Scholar
• Export Citation

Osugi Y, et al. Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation. Int J Hematol 2006; 83:454–458. doi: 10.1532/IJH97.05183

• PubMed
Osugi Y, Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation. Int J Hematol 2006; 83:454–458. doi: 10.1532/IJH97.05183)| false
• Search Google Scholar
• Export Citation

Abboud I, et al. Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: Monitoring and management guidelines. Semin Hematol 2012; 49:73–82. doi: 10.1053/j.seminhematol.2011.10.008

• PubMed
Abboud I, Chronic kidney diseases in long-term survivors after allogeneic hematopoietic stem cell transplantation: Monitoring and management guidelines. Semin Hematol 2012; 49:73–82. doi: 10.1053/j.seminhematol.2011.10.008)| false
• Search Google Scholar
• Export Citation